CompoAtlas

Hydrolysed Collagen Type I & III, Grapefruit

Food supplement declared in France, decision dated 21 October 2025

Hydrolysed Collagen Type I & III, Grapefruit (Skill Nutrition) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Hydrolysat de collagène bovin. None of the rules we check flags an issue with its declared composition.

Brand
Skill Nutrition
Food business operator placing the product on the market
Olivit Sp. z o.o.
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Powder
Daily dose
1 mesure
Intended populations
General population
Objectives stated by the manufacturer (these are not authorised claims)
Skin, Joints, Hair and nails

Declaration 343018, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Hydrolysat de collagène bovinnot declared

Additives

E960, E330

Other ingredients

Jus de betterave, maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Skill Nutrition

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Hydrolysed Collagen Type I & III, Grapefruit (Skill Nutrition): composition and regulation”, https://compoatlas.com/en/supplements/products/343018-hydrolysed-collagen-type-i-iii-grapefruit, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line